<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001864158</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001817713</issuerCik>
      <issuerName>Janux Therapeutics, Inc.</issuerName>
      <secFileNumber>001-40475</secFileNumber>
      <issuerAddress>
        <com:street1>10955 VISTA SORRENTO PARKWAY</com:street1>
        <com:street2>SUITE 200</com:street2>
        <com:city>SAN DIEGO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92130</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(858) 751-4493</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Campbell David Alan</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>THE CHARLES SCHWAB CORPORATION</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>90000</noOfUnitsSold>
      <aggregateMarketValue>4350000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>52164498</noOfUnitsOutstanding>
      <approxSaleDate>09/27/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>07/24/2017</acquiredDate>
      <natureOfAcquisitionTransaction>PRIVATE PLACEMENT</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>90000</amountOfSecuritiesAcquired>
      <paymentDate>07/24/2017</paymentDate>
      <natureOfPayment>NA</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>09/27/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>06/21/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>DAVID ALAN CAMPBELL</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2878}]
144
0001864158
XXXXXXXX
LIVE
0001817713
Janux Therapeutics, Inc.
001-40475
10955 VISTA SORRENTO PARKWAY
SUITE 200
SAN DIEGO
CA
92130
(858) 751-4493
Campbell David Alan
Officer
COMMON
THE CHARLES SCHWAB CORPORATION
3000 Schwab Way
Westlake
TX
76262
90000
4350000.00
52164498
09/27/2024
NASDAQ
COMMON
07/24/2017
PRIVATE PLACEMENT
ISSUER
N
90000
07/24/2017
NA
Y
09/27/2024
06/21/2024
DAVID ALAN CAMPBELL